REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
ASIA PACIFIC ONCOLOGY & HAEMATOLOGY - VOLUME 1 |
|
Contents:
Contents
Advisory Panel
Foreword
|
Foreword
Sun Yan President, Chinese Society of Clinical Oncology (CSCO)
|
Current Issues
|
The Challenge of Eliminating Tobacco-induced Cancers in the Developing World
Douglas W Bettcher1 and Dongbo Fu2 1. Director; 2. Technical Officer, Tobacco Free Initiative, World Health Organization (WHO)
|
|
The International Union Against Cancer – Global Cancer Control
Isabel Mortara Executive Director, International Union Against Cancer (UICC)
|
|
Quality of Life of Filipino Cancer Patients
Corazon A Ngelangel Professor, Departments of Internal Medicine–Medical Oncology and Clinical Epidemiology, College of Medicine, University of the Philippines
|
Supportive Oncology
|
Low-molecular-weight Heparins in the Management of Cancer-associated Thrombosis
Guy Meyer Clinical Professor, Respiratory Medicine, Paris Descartes University, and Attending Physician, Department of Respiratory and Intensive Care Medicine, European Hospital ‘George Pompidou’
|
|
Chemotherapy-induced Anaemia
Ibrahim T Aldoss, Sue Wilson and Peter T Silberstein Division of Hematology/Oncology, Creighton University Medical Center
|
Breast Cancer
|
The Challenge of Breast Cancer in Low- and Middle-income Countries – Implementing the Breast Health Global Initiative Guidelines
Vahit Özmen1 and Benjamin O Anderson2 1. Professor of Surgery, Department of Surgery, Medical Faculty, Istanbul University; 2. Professor of Surgery, University of Washington, and Chair and Director, Breast Health Global Initiative, Fred Hutchinson Cancer Research Center
|
Lung Cancer
|
Novel Approaches to Taxane-based Chemotherapy Regimens in Lung Cancer
Tony Mok Professor, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong
|
|
Unmet Needs in the Treatment of Metastatic Non-small-cell Lung Cancer
Ji-Youn Han1 and Jin Soo Lee2 1. Chief, Lung Cancer Branch; 2. President, Research Institute and Hospital, National Cancer Centre, Korea
|
Liver Cancer
|
Antitumour Effect of Vitamin K2 on Hepatocellular Carcinoma
Jun-ichi Okano,1 Kazuya Matsumoto,2 Takakazu Nagahara,2 Keiko Hosho1 and Yoshikazu Murawaki3 1. Assistant Professor; 2. Clinical Fellow; 3. Professor, Second Department of Internal Medicine, Tottori University School of Medicine
|
Pancreatic Cancer
|
Advances in Treatment Options for Patients with Pancreatic Cancer
Carole Harris1 and David Goldstein2 1. Medical Oncology Registrar; 2. Conjoint Clinical Professor, Department of Medical Oncology, Prince of Wales Hospital
|
Prostate Cancer
|
Therapeutic Approach to Castration-resistant Prostate Cancer
Fred Saad Professor of Surgery/Urology, University of Montréal
|
|
Advances in the Treatment of Castration-resistant Prostate Cancer
Ian D Davis Medical Oncologist, Austin Health, and Head, Uro-oncology Laboratory, Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences
|
Cervical Cancer
|
Modulating Factors in Cervical Carcinogenesis
Balasubramanyam Nagarajan and Radha Munagala Cancer Institute, Chennai
|
Radiotherapy and Imaging
|
Advances in the Treatment of Metastatic Melanoma Through Radiotherapy
Bryan Burmeister Director, Department of Radiation Oncology, Princess Alexandra Hospital
|
|
The Use of Magnetic Resonance Imaging to Accurately Establish the Clinical Staging of Squamous Cell Carcinoma in the Head and Neck
Siriporn Hirunpat Chairperson, Radiology Department, and Chief, Neuro and Head and Neck Radiology Unit, Department of Radiology, Faculty of Medicine, Songklanagarind Hospital, Prince of Songkla University
|
Geriatric Oncology
|
Challenges in the Practice of Geriatric Oncology in a National Comprehensive Cancer Centre in Asia
Donald Poon Consultant Medical Oncologist, Department of Medical Oncology, National Cancer Centre Singapore
|
Haematological Cancer
|
Management of Multiple Myeloma
Patrizia Falco,1 Alessandra Larocca,2 Mario Boccadoro3 and Antonio Palumbo4 1. Resident; 2. Research Fellow; 3. Chief; 4. Chief, Myeloma Unit, Department of Oncology, Division of Haematology, University of Turin
|
|
Optimal Therapy for Multiple Myeloma
James CS Chim1 and Raymond Liang2 1. Clinical Associate Professor; 2. SH Ho Professor of Haematology and Oncology, Chair Professor in Haematology and Oncology, and Deputy Head, Department of Medicine, University of Hong Kong
|
|
Proteomics in Myeloproliferative Disorders
Pascal Mossuz Haematology Laboratory, University Hospital Grenoble
|
Coagulation Disorders
|
Current Management of Von Willebrand Disease
Augusto B Federici Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Department of Medicine and Medical Specialities, IRCCS Maggiore Policlinico Hospital, Mangiagalli and Regina Elena Foundation, University of Milan
|
Thrombosis and Haemostasis
|
Defective Fibrinolysis and Genetic or Acquired Pro-coagulant Changes Synergistically Increase the Risk of Venous Thrombosis
Mirjam E Meltzer,1,2 Frits R Rosendaal2 and Ton Lisman1,3 1. Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht; 2. Department of Clinical Epidemiology, Leiden University Medical Centre; 3. Surgical Research Laboratory, Department of Surgery, University Medical Centre Groningen, University of Groningen
|
|
Snake Venom and Haemostasis – An Overview
Ponlapat Rojnuckarin Head, Division of Haematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University
|
|
|
|
|
|